1. Home
  2. BVS vs BXC Comparison

BVS vs BXC Comparison

Compare BVS & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • BXC
  • Stock Information
  • Founded
  • BVS 2011
  • BXC 2004
  • Country
  • BVS United States
  • BXC United States
  • Employees
  • BVS N/A
  • BXC N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BXC Wholesale Distributors
  • Sector
  • BVS Health Care
  • BXC Consumer Discretionary
  • Exchange
  • BVS Nasdaq
  • BXC Nasdaq
  • Market Cap
  • BVS 462.5M
  • BXC 551.4M
  • IPO Year
  • BVS 2021
  • BXC 2004
  • Fundamental
  • Price
  • BVS $6.57
  • BXC $80.09
  • Analyst Decision
  • BVS Strong Buy
  • BXC Strong Buy
  • Analyst Count
  • BVS 5
  • BXC 5
  • Target Price
  • BVS $14.40
  • BXC $115.40
  • AVG Volume (30 Days)
  • BVS 468.3K
  • BXC 134.9K
  • Earning Date
  • BVS 08-05-2025
  • BXC 07-29-2025
  • Dividend Yield
  • BVS N/A
  • BXC N/A
  • EPS Growth
  • BVS N/A
  • BXC N/A
  • EPS
  • BVS N/A
  • BXC 4.53
  • Revenue
  • BVS $567,699,000.00
  • BXC $2,935,514,000.00
  • Revenue This Year
  • BVS N/A
  • BXC $3.40
  • Revenue Next Year
  • BVS $6.11
  • BXC $5.01
  • P/E Ratio
  • BVS N/A
  • BXC $17.69
  • Revenue Growth
  • BVS 8.60
  • BXC N/A
  • 52 Week Low
  • BVS $6.02
  • BXC $63.14
  • 52 Week High
  • BVS $14.38
  • BXC $134.79
  • Technical
  • Relative Strength Index (RSI)
  • BVS 47.42
  • BXC 53.91
  • Support Level
  • BVS $6.81
  • BXC $73.24
  • Resistance Level
  • BVS $6.59
  • BXC $80.48
  • Average True Range (ATR)
  • BVS 0.29
  • BXC 3.29
  • MACD
  • BVS -0.04
  • BXC -0.78
  • Stochastic Oscillator
  • BVS 26.27
  • BXC 45.48

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

Share on Social Networks: